First for 50 Years | Nobel Biocare
This year, Nobel Biocare celebrates being ‘First for 50 Years’. Having sold more than 11 million units worldwide, the company’s dedication to research and innovation has ensured it remains at the lead of the dental implant field.
Today, Nobel Biocare offers an array of cutting-edge solutions to not only enhance clinical outcomes, but to also enable a smooth and easy workflow.
The recently expanded portfolio of products now includes:
- NobelActive® Wide platform (WP) implant – features a 5.5mm width to satisfy stability requirements in the posterior region.
- NobelParallel® Conical Connection (CC) – a parallel-walled implant designed for reliability, enhanced osseointegration and immediate loading.
- NobelProcera® Angulated Screw Channel (ASC) abutment – offers exceptional access for implant restoration even in limited vertical space within the posterior region.
- Full-Contour Zirconia (FCZ) Implant Crown – available in eight shades for outstanding aesthetics.
All these innovations are available as part of Nobel Biocare’s new complete posterior solution – produced specifically to address common problems faced when placing and restoring implants in the posterior zone.
Highly effective as stand alone solutions, together, these products offer even better results.
So to find out how Nobel Biocare has remained ‘First for 50 Years’, discover the leading innovations available for yourself.
For more information on the Complete Posterior Solution and other exciting innovations available from Nobel Biocare, please call 0208 756 3300 or visit www.nobelbiocare.com
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.